Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.25 USD | -5.30% | -8.03% | -31.52% |
05-21 | Biodesix, Inc. to Present New Data on the Nodify XL2 Test at ATS 2024 Annual Meeting | CI |
05-13 | TD Cowen Starts Biodesix With Buy Rating, $2.80 Price Target | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-31.52% | 192M | |
-24.06% | 7.68B | |
+70.33% | 4.31B | |
-2.45% | 2.66B | |
+7.64% | 2.63B | |
-47.56% | 2.11B | |
-18.79% | 1.7B | |
-19.07% | 1.5B | |
+12.59% | 1.16B | |
-45.36% | 1.11B |
- Stock Market
- Equities
- BDSX Stock
- News Biodesix, Inc.
- Insider Buy: Biodesix